CS logo
small CS logo
Ridgeview Medical Center

Waconia, Minnesota, United States
Medical center in Waconia, Minnesota
500 S Maple St, Waconia, MN 55387

About Ridgeview Medical Center


"Receive quality health care delivered with compassion from Ridgeview in Waconia, MN. Visit Ridgeview to care for a wide variety of your family's health needs including a 24/7 Emergency Department, a Birthing Center and NICU, specialty services and programs, and much more."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Ridgeview Medical Center


During the past decade, Ridgeview Medical Center conducted 171 clinical trials. In the 10-year time frame, 171 clinical trials started and 233 clinical trials were completed, i.e. on average, 136.3% percent of trials that started reached the finish line to date. In the past 5 years, 75 clinical trials started and 84 clinical trials were completed. i.e. 112% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Ridgeview Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 161 trials, followed by "Alliance for Clinical Trials in Oncology" with 120 trials sponsored, "SWOG Cancer Research Network" with 59 trials sponsored, "Eastern Cooperative Oncology Group" with 34 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 34 trials sponsored. Other sponsors include 64 different institutions and companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ridgeview Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 305 trials as a collaborator, "NRG Oncology" with 41 trials as a collaborator, "NCIC Clinical Trials Group" with 17 trials as a collaborator, "Cancer and Leukemia Group B" with 15 trials as a collaborator and "SWOG Cancer Research Network" with 14 trials as a collaborator. Other collaborators include 78 different institutions and companies that were collaborators in the rest 46 trials.

Clinical Trials Conditions at Ridgeview Medical Center


According to Clinical.Site data, the most researched conditions in "Ridgeview Medical Center" are "Breast Cancer" (43 trials), "Lung Cancer" (21 trials), "Lymphoma" (17 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials) and "Colorectal Cancer" (12 trials). Many other conditions were trialed in "Ridgeview Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Ridgeview Medical Center


Most popular intervention types in "Ridgeview Medical Center" are "Drug" (378 trials), "Other" (235 trials), "Biological" (184 trials), "Procedure" (96 trials) and "Radiation" (78 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (104 trials), "Quality-of-Life Assessment" (85 trials), "Questionnaire Administration" (50 trials), "Paclitaxel" (42 trials) and "placebo" (37 trials). Other intervention names were less common.

Clinical Trials Genders at Ridgeview Medical Center


The vast majority of trials in "Ridgeview Medical Center" are 371 trials for "All" genders, 81 trials for "Female" genders and 18 trials for "Male" genders.

Clinical Trials Status at Ridgeview Medical Center


Currently, there are NaN active trials in "Ridgeview Medical Center". undefined are not yet recruiting, 67 are recruiting, 139 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 219 completed trials in Ridgeview Medical Center, 7 suspended trials, and 30 terminated clinical trials to date.
Out of the total trials that were conducted in Ridgeview Medical Center, 15 "Phase 1" clinical trials were conducted, 230 "Phase 2" clinical trials and 209 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 13 trials that are defined as “Not Applicable".